Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

28 Jan 2014 14:27

RNS Number : 7051Y
Standard Life Euro Pri Eqty Tst PLC
28 January 2014
 

 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 31 December 2013

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 October 2013 to 31 December 2013. This announcement constitutes the Company's first interim management statement for the year ending 30 September 2014 in accordance with rule 4.3 of the UK Listing Authority's Disclosure Rules and Transparency Rules. This interim statement summarises information as at 31 December 2013 and any material developments up to 28 January 2014.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's audited net asset value per ordinary share ("NAV") was 244.2p at 30 September 2013 (diluted - 243.4p). The Company's NAV at 31 December 2013 will be announced on or around 18 March 2014. The share price of the Company's ordinary shares was 204.0p at 31 December 2013, compared to 198.0p at 30 September 2013, a rise of 3.0% over the quarter. Over the same period the MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) rose by 5.6% and 4.8% respectively.

 

Financial position

 

The quarter ended 31 December 2013 saw an increase in new investment and realisation activity in the European private equity market. The value of all new private equity transactions in the European private equity market announced during the quarter was €23.6 billion (quarter ended 30 September 2013 - €16.9 billion), of which €21.1 billion comprised buy-out transactions (quarter ended 30 September 2013 - €15.4 billion).

 

Distributions received by the Company during the quarter ended 31 December 2013 were £39.7 million (quarter ended 30 September 2013 - £24.6 million) and the Company funded £9.4 million of draw downs (quarter ended 30 September 2013 - £11.2 million).

 

In line with the Company's investment strategy, a new commitment of €30.0 million was made to Nordic Capital VIII in October 2013. In addition, the Company acquired through a secondary purchase an original commitment of €20.0 million to 3i Eurofund V in December 2013. The fund interest was acquired at a 2.5% discount to the 30 June 2013 valuation of the fund, adjusted for subsequent cashflows. The unrealised valuation of the fund rose by 5.1% at the most recent valuation date, being 30 September 2013. The purchase price for the fund interest was £8.2 million and the Company assumed outstanding commitments of £0.7 million. The Company already held an existing original commitment of €40 million to 3i Eurofund V.

 

At 31 December 2013 the Company had outstanding commitments of £192.6 million to 41 private equity fund interests (30 September 2013 - £178.5 million and 40 fund interests).

 

On 11 December 2013 the Company acquired 350,000 ordinary shares in the Company, through a share buy-back transaction, for a total of £693,000. The ordinary shares were acquired at an average price of 198.0p and at a discount to the prevailing diluted NAV of 18.7%. The ordinary shares acquired have been cancelled.

 

At 31 December 2013 the Company had a cash balance, including holdings in liquidity funds, of £63.4 million (30 September 2013 - cash balance of £42.3 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Events and transactions in the subsequent period to 28 January 2014

 

During the period from 1 January to 27 January 2014 the Company received £2.0 million of distributions and funded £1.7 million of draw downs. At 27 January 2014 the Company had a cash balance, including holdings in liquidity funds, of £59.8 million and outstanding commitments of £189.4 million.

 

On 24 January 2014 the Company acquired 1,250,000 ordinary shares in the Company, through a share buy-back transaction, for a total of £2,475,000. The ordinary shares were acquired at an average price of 198.0p and at a discount to the prevailing diluted NAV of 18.7%. The ordinary shares acquired have been cancelled.

 

On 31 December 2013 the Company applied to the UK Listing Authority and the Stock Exchange for 100,000 ordinary shares to be admitted to the Official List in relation to the conversion of founder A shares. This represented the final conversion of founder A shares and the new ordinary shares were granted admission on 6 January 2014. The Company currently has 163,597,294 ordinary shares in issue.

 

At the Company's annual general meeting held earlier today shareholders approved a final dividend for the year ended 30 September 2013 of 5.0p per ordinary share. The final dividend will be paid on 30 January 2014. The cash cost of the final dividend is £8.2 million.

 

There are no other material events or transactions to announce.

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDBUDDBGSI
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.